Sotrovimab-emergent resistance in SARS-CoV-2 Omicron: A series of three cases
J Clin Virol Plus
.
2022 Aug;2(3):100097.
doi: 10.1016/j.jcvp.2022.100097.
Epub 2022 Jun 28.
Authors
Daniele Focosi
1
,
Federica Novazzi
2
3
,
Andreina Baj
2
3
,
Francesca Drago Ferrante
2
,
Sara Boutahar
2
3
,
Angelo Paolo Genoni
2
3
,
Daniela Dalla Gasperina
4
3
,
Fabrizio Maggi
2
3
Affiliations
1
North-Western Tuscany Blood Bank, Pisa University Hospital, Italy.
2
Ospedale di Circolo e Fondazione Macchi, ASST Sette Laghi, Varese, Italy.
3
University of Insubria, Varese, Italy.
4
Division of Infectious Diseases, ASST Sette Laghi, Varese, Italy.
PMID:
35789899
PMCID:
PMC9238025
DOI:
10.1016/j.jcvp.2022.100097
No abstract available
Keywords:
Omicron; SARS-CoV-2; Sotrovimab; Spike: E340.